Literature DB >> 9343210

Transcriptional activation of the vascular cell adhesion molecule-1 gene in T lymphocytes expressing human T-cell leukemia virus type 1 Tax protein.

H Valentin1, I Lemasson, S Hamaia, H Cassé, S König, C Devaux, L Gazzolo.   

Abstract

Recruitment and extravasation of T cells through the blood-brain barrier are favored by adhesion molecule-mediated interactions of circulating T cells with endothelial cells. Since a common pathological finding in human T-cell leukemia virus type 1 (HTLV-1)-associated diseases is the infiltration of HTLV-1-infected T lymphocytes into various organs, we have looked for the profile of adhesion molecules expressed by HTLV-1-transformed T cells. Flow cytometry analysis indicated that these cells were expressing high levels of vascular cell adhesion molecule 1 (VCAM-1 [CD106]), a 110-kDa member of the immunoglobulin gene superfamily, first identified on endothelial cells stimulated with inflammatory cytokines. This adhesion molecule was also expressed by T cells obtained from one patient with HTLV-1-associated myelopathy/tropical spastic paraparesis but not by activated T cells isolated from one normal blood donor. The role of the viral trans-activator Tax protein in the induction of VCAM-1 was first indicated by the detection of this adhesion molecule on Jurkat T-cell clones stably expressing the tax gene. The effect of Tax on VCAM-1 gene transcription was next confirmed in JPX-9 cells, a subclone of Jurkat cells, carrying the tax sequences under the control of an inducible promoter. Furthermore, deletion and mutation analyses of the VCAM-1 promoter performed with chloramphenicol acetyltransferase constructs revealed that Tax was trans activating the VCAM-1 promoter via two NF-kappaB sites present at bp -72 and -57 in the VCAM-1 gene promoter, with both of them being required for the Tax-induced expression of this adhesion molecule. Finally, gel mobility shift assays demonstrated the nuclear translocation of proteins specifically bound to these two NF-kappaB motifs, confirming that VCAM-1 was induced on Tax-expressing cells in a kappaB-dependent manner. Collectively, these results therefore suggest that the exclusive Tax-induced expression of VCAM-1 on T cells may represent a pivotal event in the progression of HTLV-1-associated diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343210      PMCID: PMC192316     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Adult T-cell leukemia: clinical and hematologic features of 16 cases.

Authors:  T Uchiyama; J Yodoi; K Sagawa; K Takatsuki; H Uchino
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

2.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

Review 3.  Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection.

Authors:  G Franchini
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

4.  An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.

Authors:  I Lemasson; L Briant; B Hague; N Coudronnière; L Heron; C David; C Rebouissou; T Kindt; C Devaux
Journal:  J Immunol       Date:  1996-01-15       Impact factor: 5.422

Review 5.  Molecular interactions between HTLV-1 Tax protein and the NF-kappa B/kappa B transcription complex.

Authors:  J Hiscott; L Petropoulos; J Lacoste
Journal:  Virology       Date:  1995-12-01       Impact factor: 3.616

6.  Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells.

Authors:  I Miyoshi; I Kubonishi; S Yoshimoto; T Akagi; Y Ohtsuki; Y Shiraishi; K Nagata; Y Hinuma
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

7.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

8.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Restricted expression of human T-cell leukemia--lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes.

Authors:  S Z Salahuddin; P D Markham; F Wong-Staal; G Franchini; V S Kalyanaraman; R C Gallo
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

10.  Binding of host-cell factors to DNA sequences in the long terminal repeat of human T-cell leukemia virus type I: implications for viral gene expression.

Authors:  J K Nyborg; W S Dynan; I S Chen; W Wachsman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  11 in total

1.  Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Authors:  Guangyong Ma; Jun-Ichirou Yasunaga; Koichi Ohshima; Tadashi Matsumoto; Masao Matsuoka
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

2.  Altered expression of tyrosine kinases of the Src and Syk families in human T-cell leukemia virus type 1-infected T-cell lines.

Authors:  R Weil; J P Levraud; M D Dodon; C Bessia; U Hazan; P Kourilsky; A Israël
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

Review 3.  Cell surface markers in HTLV-1 pathogenesis.

Authors:  Andrea K Kress; Ralph Grassmann; Bernhard Fleckenstein
Journal:  Viruses       Date:  2011-08-16       Impact factor: 5.048

Review 4.  Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission.

Authors:  Christine Gross; Andrea K Thoma-Kress
Journal:  Viruses       Date:  2016-03-09       Impact factor: 5.048

Review 5.  Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.

Authors:  Yoshimi Enose-Akahata; Ashley Vellucci; Steven Jacobson
Journal:  Front Microbiol       Date:  2017-12-21       Impact factor: 5.640

6.  Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP.

Authors:  Tadasuke Naito; Jun-Ichirou Yasunaga; Yuichi Mitobe; Kazumasa Shirai; Hiroe Sejima; Hiroshi Ushirogawa; Yuetsu Tanaka; Tatsufumi Nakamura; Kousuke Hanada; Masahiro Fujii; Masao Matsuoka; Mineki Saito
Journal:  Retrovirology       Date:  2018-11-06       Impact factor: 4.602

Review 7.  Virus-Mediated Cell-Cell Fusion.

Authors:  Héloïse Leroy; Mingyu Han; Marie Woottum; Lucie Bracq; Jérôme Bouchet; Maorong Xie; Serge Benichou
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

8.  Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity.

Authors:  Sonia Gauthier; Isabelle Pelletier; Michel Ouellet; Amandine Vargas; Michel J Tremblay; Sachiko Sato; Benoit Barbeau
Journal:  Retrovirology       Date:  2008-11-25       Impact factor: 4.602

9.  Microarray analysis of tumor necrosis factor alpha induced gene expression in U373 human glioblastoma cells.

Authors:  Jens Schwamborn; Antje Lindecke; Margitta Elvers; Volker Horejschi; Martin Kerick; Mehran Rafigh; Julia Pfeiffer; Maria Prüllage; Barbara Kaltschmidt; Christian Kaltschmidt
Journal:  BMC Genomics       Date:  2003-11-25       Impact factor: 3.969

Review 10.  Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Yoshimi Enose-Akahata; Steven Jacobson
Journal:  Retrovirology       Date:  2019-11-29       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.